250 related articles for article (PubMed ID: 25118642)
1. Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection.
Curran T; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
J Gastrointest Surg; 2015 Jan; 19(1):152-60; discussion 160. PubMed ID: 25118642
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
Conrad C; Kutlu OC; Dasari A; Chan JA; Vauthey JN; Adams DB; Kim M; Fleming JB; Katz MH; Lee JE
J Gastrointest Surg; 2016 Dec; 20(12):1966-1974. PubMed ID: 27714644
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors.
Zhang Z; Liu M; Ji S; Luo G; Xu W; Liu W; Hu Q; Sun Q; Ye Z; Qin Y; Fan G; Yu X; Xu X
Pancreas; 2020 Mar; 49(3):381-386. PubMed ID: 32132507
[TBL] [Abstract][Full Text] [Related]
4. A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors.
Gaitanidis A; Patel D; Nilubol N; Tirosh A; Kebebew E
J Clin Endocrinol Metab; 2018 Jan; 103(1):187-195. PubMed ID: 29069375
[TBL] [Abstract][Full Text] [Related]
5. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
[TBL] [Abstract][Full Text] [Related]
6. Regional Metastatic Behavior of Nonfunctional Pancreatic Neuroendocrine Tumors: Impact of Lymph Node Positivity on Survival.
Jutric Z; Grendar J; Hoen HM; Cho SW; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF
Pancreas; 2017 Aug; 46(7):898-903. PubMed ID: 28697130
[TBL] [Abstract][Full Text] [Related]
7. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
[TBL] [Abstract][Full Text] [Related]
8. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
Sahara K; Tsilimigras DI; Mehta R; Moro A; Paredes AZ; Lopez-Aguiar AG; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho C; Beems M; Dillhoff M; Maithel SK; Endo I; Pawlik TM
Ann Surg Oncol; 2020 Apr; 27(4):1203-1212. PubMed ID: 31838609
[TBL] [Abstract][Full Text] [Related]
9. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
[TBL] [Abstract][Full Text] [Related]
10. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
[TBL] [Abstract][Full Text] [Related]
11. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
[TBL] [Abstract][Full Text] [Related]
12. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.
Zhang XF; Xue F; Dong DH; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Lv Y; Maithel SK; Pawlik TM
Ann Surg; 2021 Jul; 274(1):e28-e35. PubMed ID: 31356277
[TBL] [Abstract][Full Text] [Related]
13. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
Tsutsumi K; Ohtsuka T; Mori Y; Fujino M; Yasui T; Aishima S; Takahata S; Nakamura M; Ito T; Tanaka M
J Gastroenterol; 2012 Jun; 47(6):678-85. PubMed ID: 22350698
[TBL] [Abstract][Full Text] [Related]
14. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
[TBL] [Abstract][Full Text] [Related]
15. Indications for Surgical Resection in Low-Grade Pancreatic Neuroendocrine Tumors.
Fitzgerald TL; Mosquera C; Vora HS; Vohra NA; Zervos EE
Am Surg; 2016 Aug; 82(8):737-42. PubMed ID: 27657591
[TBL] [Abstract][Full Text] [Related]
16. Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma.
Ashfaq A; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
J Gastrointest Surg; 2014 Nov; 18(11):1929-35. PubMed ID: 24916590
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma.
Malleo G; Maggino L; Nobile S; Casciani F; Cacciatori N; Paiella S; Luchini C; Rusev B; Capelli P; Marchegiani G; Bassi C; Salvia R
Eur J Surg Oncol; 2020 Sep; 46(9):1734-1741. PubMed ID: 32327367
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.
Postlewait LM; Ethun CG; Baptiste GG; Le N; McInnis MR; Cardona K; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK
J Surg Oncol; 2016 Sep; 114(4):440-5. PubMed ID: 27334541
[TBL] [Abstract][Full Text] [Related]
19. Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors.
Sharpe SM; In H; Winchester DJ; Talamonti MS; Baker MS
J Gastrointest Surg; 2015 Jan; 19(1):117-23; discussion 123. PubMed ID: 25155459
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
Sallinen V; Haglund C; Seppänen H
Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
